292 filings
Page 4 of 15
8-K
r9hn8wuvm8eb
27 Jun 22
Other Events
7:05am
8-K
9l0ut8gff8c dbs9frxc
7 Jun 22
Submission of Matters to a Vote of Security Holders
4:05pm
8-K
001g bc8njv6p7imla
2 Jun 22
Axsome Therapeutics Presents New Data from the GEMINI Trial Demonstrating Efficacy of AXS-05 on Anhedonia in Patients with Major Depressive Disorder
7:05am
8-K
0yl9iawab9x
1 Jun 22
Other Events
7:05am
8-K
rzxt4
31 May 22
Other Events
7:06am
8-K
1carf
18 May 22
Other Events
7:05am
8-K
ccsd ce6qegvs
9 May 22
Completion of Acquisition or Disposition of Assets
7:05am
S-8
16gsrduwb0m
2 May 22
Registration of securities for employees
5:13pm
8-K
06jy66nkbz8w
2 May 22
Axsome Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Update
7:06am
8-K
u7p 1pb5k
25 Apr 22
Other Events
7:02am
8-K
ua3d5k5ue1en sanwj
19 Apr 22
Other Events
7:00am
8-K/A
u2eepq72jva phoc
31 Mar 22
Asset Purchase Agreement
4:45pm
8-K
usljhw6w
28 Mar 22
Axsome Therapeutics to Acquire Sunosi® from Jazz Pharmaceuticals, Expanding Axsome’s Leadership in Neuroscience
8:00am
424B5
oceaz 4663ao3fg
1 Mar 22
Prospectus supplement for primary offering
5:21pm
8-K
kuc c2ygxm
1 Mar 22
Entry into a Material Definitive Agreement
5:10pm
8-K
luuou0u3nh6fx 2p
1 Mar 22
Axsome Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
7:06am
8-K
nsbch9q9
7 Feb 22
Other Events
4:00pm